pharma · Juvenile idiopathic arthritis · juvenile idiopathic arthritis
Alfasigma
Alfasigma S.p.A.
Alfasigma S.p.A is a pharma organization headquartered in BOLOGNA, IT. Primary therapeutic focus areas include Juvenile idiopathic arthritis, juvenile idiopathic arthritis, Axial Spondyloarthritis, Ulcerative colitis, Rh
BOLOGNA, IT HQ
2,481 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- BOLOGNA, IT
- Employees
- 2,481
- Programs
- 8
- Drugs
- 8
- Patents
- 25
GS-US-418-3899
Phase 3 · small molecule · Ulcerative Colitis (UC)
GS-US-418-3899 for Ulcerative Colitis (UC) is a Phase 3 program (small_molecule) at Alfasigma S.p.A. with 1 ClinicalTrials.gov record(s).
Internal code GS-US-418-3899
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Alfasigma S.p.A.
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Ulcerative Colitis (UC)
- Status
- active
- Trials
- 1